↓ Skip to main content

Bone marrow aspirate concentrate for the treatment of osteochondral lesions of the talus: a systematic review of outcomes

Overview of attention for article published in Journal of Experimental Orthopaedics, November 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
58 Mendeley
Title
Bone marrow aspirate concentrate for the treatment of osteochondral lesions of the talus: a systematic review of outcomes
Published in
Journal of Experimental Orthopaedics, November 2016
DOI 10.1186/s40634-016-0069-x
Pubmed ID
Authors

Jorge Chahla, Mark E. Cinque, Jason M. Schon, Daniel J. Liechti, Lauren M. Matheny, Robert F. LaPrade, Thomas O. Clanton

Abstract

The goal of this perform a systematic review on the outcomes of bone marrow aspirate concentrate (BMAC) for the treatment of chondral defects and osteoarthritis (OA) of the talus. The systematic search performed identified 47 studies after duplicates were removed. After inclusion criteria were applied four studies were considered for insightful analysis for the treatment of focal chondral defects in the foot and ankle with the use of BMAC. Three studies were retrospective and one study was prospective in nature. One study was a comparative cohort study and three studies were case series. This review denotes that there exists an overwhelming paucity of long-term data and high-level evidence supporting BMAC for the treatment of chondral defects. Nonetheless, the evidence available showed varying degrees of beneficial results of BMAC for the treatment of ankle cartilage defects. The limited literature presented in this review demonstrates the need for more advanced, comparative studies to further investigate the efficacy, safety and techniques for BMAC in the treatment of OLTs. The authors recommend that BMAC therapy should be performed with careful consideration until the application and target population for this treatment are established.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Austria 1 2%
Unknown 56 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 21%
Researcher 9 16%
Student > Bachelor 6 10%
Other 5 9%
Student > Postgraduate 5 9%
Other 11 19%
Unknown 10 17%
Readers by discipline Count As %
Medicine and Dentistry 27 47%
Agricultural and Biological Sciences 4 7%
Biochemistry, Genetics and Molecular Biology 3 5%
Nursing and Health Professions 3 5%
Physics and Astronomy 1 2%
Other 3 5%
Unknown 17 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2018.
All research outputs
#5,931,133
of 22,663,150 outputs
Outputs from Journal of Experimental Orthopaedics
#54
of 316 outputs
Outputs of similar age
#90,886
of 310,867 outputs
Outputs of similar age from Journal of Experimental Orthopaedics
#1
of 6 outputs
Altmetric has tracked 22,663,150 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 316 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,867 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them